MSB 5.24% $1.11 mesoblast limited

Given their recent hiccups and shortfalls in other trials, I'm...

  1. 782 Posts.
    lightbulb Created with Sketch. 293
    Given their recent hiccups and shortfalls in other trials, I'm sure this extra money will be a great benefit to the company and to investors/shareholders, alleviating the need for any capital raises in short term future.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.